FR2793489B1 - (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]-heptane, ses sels d'addition et procede de preparation - Google Patents

(1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]-heptane, ses sels d'addition et procede de preparation

Info

Publication number
FR2793489B1
FR2793489B1 FR0005940A FR0005940A FR2793489B1 FR 2793489 B1 FR2793489 B1 FR 2793489B1 FR 0005940 A FR0005940 A FR 0005940A FR 0005940 A FR0005940 A FR 0005940A FR 2793489 B1 FR2793489 B1 FR 2793489B1
Authority
FR
France
Prior art keywords
bicyclo
heptane
dimethylamino
ethoxy
tri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0005940A
Other languages
English (en)
Other versions
FR2793489A1 (fr
Inventor
Gyula Lukacs
Gyula Simig
Tibor Mezei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2793489A1 publication Critical patent/FR2793489A1/fr
Application granted granted Critical
Publication of FR2793489B1 publication Critical patent/FR2793489B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/12—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0005940A 1999-05-11 2000-05-10 (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]-heptane, ses sels d'addition et procede de preparation Expired - Fee Related FR2793489B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9901559A HU227114B1 (en) 1999-05-11 1999-05-11 (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Publications (2)

Publication Number Publication Date
FR2793489A1 FR2793489A1 (fr) 2000-11-17
FR2793489B1 true FR2793489B1 (fr) 2004-04-02

Family

ID=89998272

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0005941A Expired - Fee Related FR2793490B1 (fr) 1999-05-11 2000-05-10 Procede de preparation du (1r,2s,4r)-(-)-2-[(2'-{n,n- dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]- bicyclo[2.2.1]-heptane et ses sels d'addition d'acide pharmaceutiquement acceptables
FR0005940A Expired - Fee Related FR2793489B1 (fr) 1999-05-11 2000-05-10 (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]-heptane, ses sels d'addition et procede de preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR0005941A Expired - Fee Related FR2793490B1 (fr) 1999-05-11 2000-05-10 Procede de preparation du (1r,2s,4r)-(-)-2-[(2'-{n,n- dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]- bicyclo[2.2.1]-heptane et ses sels d'addition d'acide pharmaceutiquement acceptables

Country Status (38)

Country Link
US (3) US6242386B1 (fr)
EP (4) EP1177167B1 (fr)
JP (2) JP4536265B2 (fr)
KR (3) KR100581489B1 (fr)
CN (2) CN1173928C (fr)
AR (2) AR020860A1 (fr)
AT (4) ATE386714T1 (fr)
AU (2) AU777737B2 (fr)
BG (2) BG64673B1 (fr)
BR (2) BR0010406A (fr)
CA (2) CA2373193A1 (fr)
CO (1) CO5170480A1 (fr)
CZ (4) CZ20014051A3 (fr)
DE (4) DE60002117T2 (fr)
DK (4) DK1052243T3 (fr)
EA (2) EA002163B1 (fr)
EE (2) EE200100596A (fr)
ES (4) ES2208328T3 (fr)
FR (2) FR2793490B1 (fr)
HK (2) HK1031220A1 (fr)
HR (2) HRP20000290B1 (fr)
HU (1) HU227114B1 (fr)
IL (4) IL146421A0 (fr)
IS (2) IS6152A (fr)
LT (2) LT4928B (fr)
MX (2) MXPA01011423A (fr)
MY (2) MY123523A (fr)
NO (2) NO321486B1 (fr)
NZ (2) NZ515917A (fr)
PL (2) PL202956B1 (fr)
PT (4) PT1177166E (fr)
SI (4) SI1177167T1 (fr)
SK (4) SK285635B6 (fr)
TR (2) TR200200148T2 (fr)
TW (2) TW528742B (fr)
UA (2) UA49974C2 (fr)
WO (2) WO2000068183A2 (fr)
ZA (2) ZA200108958B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6589996B2 (en) 2000-03-17 2003-07-08 Orion Corporation Treatment of disorders relating to the serotonergic system
US20040082665A1 (en) * 2001-01-22 2004-04-29 Outi Maki-Ikola Method for treating stress or tension
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
HUP0301906A3 (en) * 2003-06-23 2006-03-28 Egis Gyogyszergyar Nyilvanosan Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
CZ2006623A3 (cs) * 2004-03-12 2007-01-24 Egis Gyogyszergyár Nyrt. Kombinace deramciklanu a opioidů jako analgetik
JP4916680B2 (ja) * 2005-06-30 2012-04-18 株式会社半導体エネルギー研究所 半導体装置の作製方法、剥離方法
US20080258121A1 (en) * 2007-04-23 2008-10-23 Hasan Farooq Fire Retardant Composition
MX2012005634A (es) 2009-11-19 2012-09-07 Yissum Res Dev Co Canfenos arilados novedosos, procesos para su preparacion y usos.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179164B (en) * 1979-12-14 1982-08-28 Egyt Gyogyszervegyeszeti Gyar Process for producing cycloalkyl-ethers of alkanolamines
HU212574B (en) * 1990-09-21 1996-08-29 Egyt Gyogyszervegyeszeti Gyar Process for producing (1r,2s)-(-)-2-phenyl-(2'-dimethyl-amino-etoxy)-1,7,7-trimethyl-bicyclo[2.2.1.]heptane
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
HU226061B1 (en) 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same

Also Published As

Publication number Publication date
PT1052243E (pt) 2003-12-31
BR0010406A (pt) 2002-02-13
SK16232001A3 (sk) 2002-04-04
BG64442B1 (en) 2005-02-28
WO2000068181A3 (fr) 2001-06-28
WO2000068181A2 (fr) 2000-11-16
SI1177167T1 (en) 2004-04-30
DK1052243T3 (da) 2003-11-24
DE60038112T2 (de) 2009-02-12
CZ20001723A3 (cs) 2000-12-13
SK16242001A3 (sk) 2002-04-04
CZ20014051A3 (cs) 2002-05-15
EP1177167B1 (fr) 2003-10-22
CZ290734B6 (cs) 2002-10-16
EP1052243A2 (fr) 2000-11-15
US6335469B1 (en) 2002-01-01
EA002163B1 (ru) 2001-12-24
US20020040164A1 (en) 2002-04-04
LT4928B (lt) 2002-07-25
ES2194643T3 (es) 2003-12-01
SK6902000A3 (en) 2000-12-11
AR020860A1 (es) 2002-05-29
HU227114B1 (en) 2010-07-28
ES2203373T3 (es) 2004-04-16
HK1031372A1 (en) 2001-06-15
KR20020010914A (ko) 2002-02-06
PL340108A1 (en) 2000-11-20
DE60006097D1 (de) 2003-11-27
NO321486B1 (no) 2006-05-15
LT4927B (lt) 2002-07-25
DE60002117T2 (de) 2003-12-24
UA49974C2 (uk) 2002-10-15
TR200200148T2 (tr) 2002-06-21
EP1177166B1 (fr) 2008-02-20
PL202956B1 (pl) 2009-08-31
BG104416A (en) 2001-03-30
TR200200147T2 (tr) 2002-06-21
ATE237579T1 (de) 2003-05-15
PT1052245E (pt) 2003-09-30
MXPA01011420A (es) 2002-06-04
EE04672B1 (fr) 2006-08-15
CA2369393A1 (fr) 2000-11-16
ATE252544T1 (de) 2003-11-15
PT1177167E (pt) 2004-03-31
NO20015352D0 (no) 2001-11-01
IL146420A0 (en) 2002-07-25
ATE386714T1 (de) 2008-03-15
LT2001109A (en) 2002-03-25
CN1353687A (zh) 2002-06-12
ES2302694T3 (es) 2008-08-01
EP1052245A2 (fr) 2000-11-15
HU9901559D0 (en) 1999-07-28
CN1173928C (zh) 2004-11-03
CN1353686A (zh) 2002-06-12
CZ20001722A3 (cs) 2000-12-13
SK285635B6 (sk) 2007-05-03
BG104417A (en) 2001-03-30
NO20015336D0 (no) 2001-10-31
SI1177166T1 (sl) 2008-08-31
FR2793490B1 (fr) 2004-04-23
AU776696B2 (en) 2004-09-16
EP1052243A3 (fr) 2001-02-28
AR023900A1 (es) 2002-09-04
EA200000411A3 (ru) 2001-02-26
EA002164B1 (ru) 2001-12-24
EP1177167A2 (fr) 2002-02-06
KR20010112486A (ko) 2001-12-20
IL146420A (en) 2007-06-03
NO20015336L (no) 2002-01-08
CO5170480A1 (es) 2002-06-27
HRP20000291A2 (en) 2001-06-30
JP2002544184A (ja) 2002-12-24
EP1052243B1 (fr) 2003-07-30
WO2000068183A2 (fr) 2000-11-16
EP1052245B1 (fr) 2003-04-16
ZA200108958B (en) 2002-10-30
HRP20000290A2 (en) 2005-02-28
DE60038112D1 (de) 2008-04-03
MY122508A (en) 2006-04-29
BG64673B1 (bg) 2005-11-30
EE04638B1 (et) 2006-06-15
HK1031220A1 (en) 2001-06-08
KR20060010874A (ko) 2006-02-02
FR2793490A1 (fr) 2000-11-17
UA61122C2 (uk) 2003-11-17
EP1052245A3 (fr) 2001-02-28
NZ515917A (en) 2004-02-27
TWI286541B (en) 2007-09-11
DE60038112T8 (de) 2009-05-28
DE60006097T2 (de) 2004-06-17
MY123523A (en) 2006-05-31
CA2373193A1 (fr) 2000-11-16
DE60004126D1 (de) 2003-09-04
HUP9901559A2 (hu) 2002-01-28
CZ20014050A3 (cs) 2002-05-15
EA200000410A3 (ru) 2001-02-26
KR100685071B1 (ko) 2007-02-22
HRP20000291B1 (en) 2005-06-30
PT1177166E (pt) 2008-06-02
TW528742B (en) 2003-04-21
EE200100595A (et) 2003-02-17
JP4536265B2 (ja) 2010-09-01
SK285780B6 (sk) 2007-08-02
DE60002117D1 (de) 2003-05-22
DE60004126T2 (de) 2004-04-22
JP4031203B2 (ja) 2008-01-09
EA200000410A2 (ru) 2000-12-25
EP1177166A2 (fr) 2002-02-06
NO20015352L (no) 2002-01-08
IL146421A0 (en) 2002-07-25
CZ291329B6 (cs) 2003-02-12
HRP20000290B1 (en) 2007-08-31
CA2369393C (fr) 2010-07-06
AU777737B2 (en) 2004-10-28
KR100581489B1 (ko) 2006-05-22
SK6892000A3 (en) 2000-12-11
US6242386B1 (en) 2001-06-05
DK1177167T3 (da) 2004-03-01
DK1177166T3 (da) 2008-06-16
DK1052245T3 (da) 2003-08-11
CN1325465C (zh) 2007-07-11
EA200000411A2 (ru) 2000-12-25
IS2570B (is) 2010-01-15
LT2001108A (en) 2002-03-25
NO321487B1 (no) 2006-05-15
SI1052245T1 (en) 2003-10-31
SI1052243T1 (en) 2004-02-29
EE200100596A (et) 2003-02-17
IS6152A (is) 2001-11-09
IL146421A (en) 2008-11-26
US6624201B2 (en) 2003-09-23
BR0010412A (pt) 2002-02-13
FR2793489A1 (fr) 2000-11-17
IS6153A (is) 2001-11-09
AU4600300A (en) 2000-11-21
NZ515918A (en) 2004-02-27
AU4773100A (en) 2000-11-21
MXPA01011423A (es) 2002-06-04
ATE246170T1 (de) 2003-08-15
WO2000068183A3 (fr) 2001-07-26
JP2002544185A (ja) 2002-12-24
ZA200108956B (en) 2003-02-17
ES2208328T3 (es) 2004-06-16
PL340107A1 (en) 2000-11-20

Similar Documents

Publication Publication Date Title
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
DZ3220A1 (fr) Composes actifs au plan pharmaceutique
WO2002009754A1 (fr) Nouveaux remedes contre le cancer
EE200100574A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
FR2793489B1 (fr) (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2- [phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]-heptane, ses sels d'addition et procede de preparation
AU2001285238A1 (en) Ultrasonic system for enhancing blood perfusion
FR2796940B1 (fr) Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
AU2001239827A1 (en) Substituted alkylene diamine compounds
EE200100573A (et) Uued ühendid, nende valmistamise meetod ning kasutamine
AU2994599A (en) Active immunization against angiogenesis-associated antigens
ITMI20001848A0 (it) Faramaci per l'incontinenza.
AU2002244946A1 (en) Drugs containing genetically modified antibody against ganglioside GD3
DZ3448A1 (fr) PROCEDE pour la PREPARATION D'UREE.
IT1314497B1 (it) Dispositivo di dosaggio dello sciroppo per macchine per lapreparazione estemporanea di bevande.
DE29815536U1 (de) Alkoholfreie pharmazeutische Zubereitung
ITMI992457A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
IT249186Y1 (it) Contenitore per fard, ombretto, rimmel o simili.
DE60001768D1 (de) Tezosentan enthaltende wässerige pharmazeutische Zubereitung
IT1320973B1 (it) Metodo per l'etichettatura di confezioni.
IT1312134B1 (it) Struttura modulare per la realizzazione di arredi urbani, eprocedimento di realizzazione.
IT248467Y1 (it) Leva per cialde d'infusione
UA3657S (uk) Упаковка для ліків "колдфлю"
IT1311985B1 (it) Procedimento per la preparazione di isosorbide-5-mononitrato.
IT1309105B1 (it) Involucro per l'imballaggio sottovuoto e procedimento di imballaggioassociato.
IT250733Y1 (it) Contenitore di struttura componibile, in particolare per la realizzazione di fioriere per arredo urbano.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120131